Histogenics

News

US biotechs Ocugen and Histogenics have announced plans to merge, creating a specialist in drugs and gene therapies for ocular diseases.

News

TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.